Dr. Mandip Shah MBBS , MS (Orthopaedics)
Sparsh Orthopedic Oncology Clinic, Ahmedabad, Gujarat
21 Years Experience
Dr. Mandip Shah –
Musculoskeletal & Orthopedic Oncologist
MBBS, MS (Orthopaedics) – Orthopedic Oncology Specialist
Dr. Mandip Shah is a leading
musculoskeletal and orthopedic oncologist based in Ahmedabad, specialising in
bone and soft‑tissue cancers of the limbs, pelvis and spine.
With more than two decades of focused experience and a high volume of limb‑salvage surgeries, he is
regarded as one of the pioneers of orthopedic oncology practice in Gujarat.
Hospital Affiliations & Clinic
Founder & Director, Sparsh Orthopedic Oncology Clinic, Ahmedabad – a dedicated centre for bone and soft‑tissue tumours and limb‑salvage surgery.
Sparsh Orthopedic Oncology Clinic is designed to offer scientific, evidence‑based and advanced care for patients with bone and soft‑tissue tumours, with a strong focus on limb preservation, multidisciplinary planning and long‑term follow‑up.
Dr. Shah’s practice is
devoted primarily to musculoskeletal oncology and complex orthopedic
reconstruction:
·
Primary bone cancers (osteosarcoma, Ewing sarcoma, chondrosarcoma)
and soft‑tissue sarcomas of the extremities and trunk.
·
Benign but aggressive bone tumours such as giant‑cell tumour, aneurysmal bone
cyst and other lesions causing structural weakness or pathological fracture.
·
Tumours involving the pelvis and spine, including technically
demanding pelvic resections and oncologic spinal procedures.
·
Limb‑salvage surgery with megaprosthetic joint reconstruction,
arthrodesis and other advanced reconstructive techniques after tumour
resection.
·
Management of pathological fractures, post‑tumour bone defects, and
complex revisions in patients previously advised amputation.
Dr. Shah strongly believes
that “limb salvage should be the norm, not the exception” wherever
oncologically safe.
His treatment philosophy is based on meticulous staging, evidence‑based oncology protocols and
tailored surgical planning that balances tumour clearance with preservation of
function and appearance.
He emphasises detailed counselling, transparent risk communication and shared
decision‑making, helping patients and families understand options such as
limb‑salvage versus amputation,
prosthetic reconstruction and long‑term surveillance.
Advanced Procedures & Expertise
Dr. Shah has particular
expertise in several advanced oncologic orthopaedic procedures:
·
Megaprosthetic Reconstruction
o Replacement of large
segments of bone around major joints (especially distal femur and proximal
tibia) with tumour prostheses after wide resection.
o Used to restore mobility and
weight‑bearing in patients who would otherwise require amputation.
·
Complex Pelvic & Spinal Tumour Surgery
o Internal hemipelvectomy and
other pelvic resections for malignant tumours involving the hip‑girdle region.
o Oncologic spine
reconstructions for selected vertebral and paraspinal tumours.
·
Limb‑Salvage in Challenging Cases
o Management of high‑grade sarcomas previously
advised amputation, using multi‑disciplinary planning and reconstructive strategies.
o Rotationplasty and
specialised reconstructive procedures in highly selected scenarios where
conventional limb‑salvage is not feasible.
·
Benign Tumour Management
o Novel curettage techniques
for giant‑cell tumour and other benign but aggressive lesions, designed to
preserve the native joint while minimising recurrence.
Supportive Care &
Multidisciplinary Approach
Dr. Shah works closely with
radiologists, medical and radiation oncologists, pathologists, physiotherapists
and prosthetic specialists to provide comprehensive, end‑to‑end care.
His teams at Sparsh and partner hospitals offer structured pre‑operative counselling, post‑operative rehabilitation
plans, prosthesis training and survivorship follow‑up for patients who undergo
major cancer surgery.
He is also actively involved in teaching and academic programmes, including
national webinars on biopsy techniques and benign paediatric bone tumours,
helping to train the next generation of orthopedic surgeons in oncologic
principles.
Through Reopine’s secure
virtual platform, Dr. Mandip Shah offers expert online consultations for
patients across India and abroad facing complex decisions about bone and soft‑tissue tumours.
Available Services via Reopine:
·
First Opinion Consultations – Evaluation of newly diagnosed bone
or soft‑tissue tumours based on uploaded imaging and biopsy reports, with
guidance on staging and treatment options.
·
Second Opinion Reviews – Independent review of planned surgeries
(including cases where amputation has been advised) to assess feasibility of
limb‑salvage or alternative
reconstruction.
·
Post‑operative & Survivorship Consults – Follow‑up guidance after cancer
surgery performed at any centre, including rehabilitation, prosthesis use and
long‑term surveillance planning.
·
Medical Tourism & Treatment Planning – Counselling for
patients considering travel to Ahmedabad for definitive surgery, aligned with
Reopine’s medical‑tourism support services.
Date: 16 Aug 2026
-
Nature of Services
- I understand that Reopine is a technology platform that connects me with independent, licensed doctors in India for medical opinion/teleconsultation.
- I acknowledge that Reopine itself does not provide medical services, diagnosis, or treatment. All medical advice is given solely by the consulting doctor.
-
Teleconsultation Limitations
- I understand that teleconsultation has inherent limitations compared to in-person consultation, including lack of physical examination and limited access to diagnostic tests.
- I agree that the medical opinion provided may be limited by the information, history, and documents I provide.
-
Emergency Situations
- I acknowledge that Reopine is not to be used in emergency or life-threatening situations.
- In case of emergencies, I shall immediately contact local healthcare providers or emergency numbers (e.g., 108 in India / 911 in USA).
-
Cross-Border Consultations
- I understand that all doctors on Reopine are licensed to practice in India only.
- If I access the platform from outside India:
- I agree that the consultation is deemed to have occurred in India under Indian law.
- I accept full responsibility for compliance with my country’s local laws.
- I waive any claim against Reopine in foreign jurisdictions.
- The information provided during this consultation is for general health guidance and educational purposes only.
- It is not a substitute for an in-person medical examination by a doctor licensed in your country.
- The doctor may offer advice or general treatment options based on information you share, but you are strongly advised to:
- Consult a locally licensed physician before starting or changing any medication or treatment.
- The consultation is conducted based on good faith, relying on the accuracy and completeness of the information you provide.
-
Data Privacy
- I consent to Reopine collecting, processing, and storing my personal and medical information in accordance with its Privacy Policy and applicable Indian data protection laws.
- I understand that my health records may be shared with consulting doctors for the purpose of the consultation.
-
Payment, Refund & Liability
- I understand that payments made are subject to Reopine’s Cancellation & Refund Policy.
- I agree that Reopine’s liability, if any, shall be limited to the amount of service fees paid by me for the disputed consultation, and not exceeding INR 10,000 in any case.
- I acknowledge that any malpractice or negligence claim lies against the individual doctor, not against Reopine.
-
Consent & Acknowledgment
By proceeding, I confirm that:
- I have read and understood the Terms & Conditions and this Consent Form.
- I voluntarily consent to teleconsultation via Reopine.
- I release Reopine from liability for outcomes beyond its control, including medical opinions of independent doctors, third-party technology failures, or my own failure to follow medical advice.
Patient’s Full Name:
Signature: ____________________________
Date: 16 Aug 2026
Subcribe to our Newsletter
Subscribe for Updates: Stay informed about the latest investor updates, financial results, and announcements by subscribing to our newsletter.